Literature DB >> 17057944

Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever.

Arzu Celebi Kobak1, Senol Kobak, Yasemin Kabasakal, Ulus Salih Akarca.   

Abstract

The proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) plays an important role on the course of disease in familial Mediterranean fever (FMF). TNF-alpha gene promoter polymorphism may be a marker of susceptibility and severity of FMF. The aim of this study is to evaluate both TNF-alpha/238 and TNF-alpha/308 genotypes and allelic distribution in patients with FMF. Forty-one FMF patients and 43 healthy volunteers were included in the study. Genomic DNA was extracted from EDTA-preserved whole blood of whole series of patients and controls. Polymorphism of TNF-alpha promoter at positions -238 and -308 were detected by using amplification refractory mutation system polymerase chain reaction. TNF-alpha/238 and TNF-alpha/308 genotype distributions and allele frequencies of FMF patients and healthy volunteers were found to be similar. Moreover, there was no association between TNF-alpha/238 and TNF-alpha/308 genotypes and the frequency of acute attacks in FMF. TNF-alpha/238 and TNF-alpha/308 promoter polymorphisms do not seem to be major genetic risk factors for susceptibility to FMF and severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057944     DOI: 10.1007/s10067-006-0430-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  14 in total

1.  Activation of the cytokine network in familial Mediterranean fever.

Authors:  N Gang; J P Drenth; P Langevitz; D Zemer; N Brezniak; M Pras; J W van der Meer; A Livneh
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Endocrine function and dysfunction in familial Mediterranean fever.

Authors:  Kostas Konstantopoulos
Journal:  Clin Rheumatol       Date:  2006-07-07       Impact factor: 2.980

3.  Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease.

Authors:  A Camarena; A Juárez; M Mejía; A Estrada; G Carrillo; R Falfán; J Zuñiga; C Navarro; J Granados; M Selman
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

4.  Tumor necrosis factor in familial Mediterranean fever.

Authors:  A Schattner; M Lachmi; A Livneh; M Pras; T Hahn
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

5.  A candidate gene for familial Mediterranean fever.

Authors: 
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

6.  Serum soluble interleukin-2 receptor levels in familial Mediterranean fever.

Authors:  E Erken; R Güneşaçar; S Ozbek; K Konca
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

7.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

8.  Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.

Authors:  Y Baykal; K Saglam; M I Yilmaz; A Taslipinar; S B Akinci; A Inal
Journal:  Clin Rheumatol       Date:  2003-05       Impact factor: 2.980

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients.

Authors:  Engin Yilmaz; Banu Balci; Sim Kutlay; Seza Ozen; Sensuvar Ertürk; Ayse Oner; Nesrin Beşbaş; Ayşin Bakkaloğlu
Journal:  Turk J Pediatr       Date:  2003 Jul-Sep       Impact factor: 0.552

View more
  1 in total

1.  Ultrasonographic evaluation of femoral cartilage thickness in patients with familial Mediterranean fever.

Authors:  Ayşe Aydemir Ekim; Fulya Bakılan; Emel Gönüllü; Hatice Hamarat
Journal:  Turk J Phys Med Rehabil       Date:  2021-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.